Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer


Dr. Maki brings over 20 years of biopharmaceutical industry experience, including leadership roles in business development, licensing, and corporate venture across both emerging biotech ventures and global pharmaceutical companies. Her background includes senior positions at industry-leading organizations such as Medarex (now part of Bristol Myers Squibb), Genentech, Merck & Co., Eli Lilly and Company, and Callio Therapeutics.



Source link

  • Related Posts

    Emerging Markets Face New Credit-Downgrade Era, S&P Global Warns

    (Bloomberg) — The Middle East war risks ending a run of net credit-rating upgrades across emerging markets and could trigger a new downgrade cycle as it fuels inflation and tightens…

    McDonald’s throws birthday party for 95-year-old

    IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing McDonald’s throws birthday party for 95-year-old 00:31 UP NEXT Trump claims ‘regime change’…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    A New Boss Takes Over Homeland Security With Less Flash but Same Mission

    WoW to get an official pride event, based on a community run that’s raised money for 12 years

    WoW to get an official pride event, based on a community run that’s raised money for 12 years

    Here’s How to Turn Your Favorite Pet Photo Into a Cute iPhone Emoji

    Here’s How to Turn Your Favorite Pet Photo Into a Cute iPhone Emoji

    Sunflower Named Special Project of Pitti Uomo’s June 2026 Edition

    Sunflower Named Special Project of Pitti Uomo’s June 2026 Edition

    Emerging Markets Face New Credit-Downgrade Era, S&P Global Warns

    Most Canadians support banning social media for those under 16: Survey

    Most Canadians support banning social media for those under 16: Survey